Fangte Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fangte Liang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Chen Zhao
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication - Fei Lin
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication - Jing He
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication - Liming Cen
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication - Lu Zhang
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication - Lu Zhao
Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China
1 shared publication
Latest Publications
- Open Access
- 4 October 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-11
GSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion
Lung ischemia/reperfusion injury (LIRI) is a complex pathophysiological process, with the histopathological hallmark of neutrophils migrating into the lungs. Neutrophil extracellular traps (NETs) have been suggested to exert a critical role in the pathogenesis of inflammation and infection in humans and animals, while the exact functions and underlying mechanisms of NETs in LIRI remain insufficiently elucidated. In this study, we investigated the role of pore-forming protein gasdermin D (GSDMD) on NETs release in LIRI induced by lung ischemia/reperfusion (I/R). We found that disulfiram, a GSDMD inhibitor, dramatically reduced NETs release and pathological injury in lung I/R in vivo and in vitro. Additionally, GSDMD caused mitochondrial DNA (mtDNA) leaking into the neutrophil cytosol, and then the cytoplasmic mtDNA activated the cGAS-STING signaling pathway and stimulated NETs formation in lung I/R. Furthermore, inhibition of cGAS/STING pathway could inhibit cytosol mtDNA mediated NETs formation.
- 4 October 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-11
Open AccessGSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion
Lung ischemia/reperfusion injury (LIRI) is a complex pathophysiological process, with the histopathological hallmark of neutrophils migrating into the lungs. Neutrophil extracellular traps (NETs) have been suggested to exert a critical role in the pathogenesis of inflammation and infection in humans and animals, while the exact functions and underlying mechanisms of NETs in LIRI remain insufficiently elucidated. In this study, we investigated the role of pore-forming protein gasdermin D (GSDMD) on NETs release in LIRI induced by lung ischemia/reperfusion (I/R). We found that disulfiram, a GSDMD inhibitor, dramatically reduced NETs release and pathological injury in lung I/R in vivo and in vitro. Additionally, GSDMD caused mitochondrial DNA (mtDNA) leaking into the neutrophil cytosol, and then the cytoplasmic mtDNA activated the cGAS-STING signaling pathway and stimulated NETs formation in lung I/R. Furthermore, inhibition of cGAS/STING pathway could inhibit cytosol mtDNA mediated NETs formation.